363 related articles for article (PubMed ID: 17606127)
1. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
3. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
[TBL] [Abstract][Full Text] [Related]
5. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
6. L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits.
Okazaki J; Komori K; Kawasaki K; Eguchi D; Ishida M; Sugimachi K
Cardiovasc Res; 1997 Dec; 36(3):429-36. PubMed ID: 9534863
[TBL] [Abstract][Full Text] [Related]
7. The nitric oxide precursor L-arginine reduces expression of hyaluronan synthase in experimental vein bypass grafts.
Dattilo JB; Dattilo MP; Crane JT; Yager DR; Makhoul RG
J Surg Res; 1998 Jan; 74(1):39-42. PubMed ID: 9536971
[TBL] [Abstract][Full Text] [Related]
8. L-arginine polymers inhibit the development of vein graft neointimal hyperplasia.
Kown MH; Yamaguchi A; Jahncke CL; Miniati D; Murata S; Grunenfelder J; Koransky ML; Rothbard JB; Robbins RC
J Thorac Cardiovasc Surg; 2001 May; 121(5):971-80. PubMed ID: 11326242
[TBL] [Abstract][Full Text] [Related]
9. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
West N; Guzik T; Black E; Channon K
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of intimal hyperplasia of venous grafts after coronary artery bypass grafting, an experimental study].
Xiao M; You W; Yuan Z; Xu G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1550-2. PubMed ID: 12609065
[TBL] [Abstract][Full Text] [Related]
11. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells.
Ohta S; Komori K; Yonemitsu Y; Onohara T; Matsumoto T; Sugimachi K
Surgery; 2002 Jun; 131(6):644-53. PubMed ID: 12075177
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid decreases cell proliferation and increases apoptosis in an animal model of vein bypass grafting.
Leville CD; Osipov VO; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
Surgery; 2000 Aug; 128(2):178-84. PubMed ID: 10922989
[TBL] [Abstract][Full Text] [Related]
14. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation.
Chaux A; Ruan XM; Fishbein MC; Ouyang Y; Kaul S; Pass JA; Matloff JM
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):604-12; discussion 612-4. PubMed ID: 9535448
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentanoic acid reduces the intimal thickening of autogenous vein grafts and enhances endothelium-derived relaxing factor.
Komori K; Ishii T; Odashiro T; Itoh H; Mawatari K; Okadome K; Sugimachi K
J Surg Res; 1995 Dec; 59(6):747-53. PubMed ID: 8538176
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
[TBL] [Abstract][Full Text] [Related]
17. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
18. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
Huynh TT; Iaccarino G; Davies MG; Svendsen E; Koch WJ; Hagen PO
Surgery; 1998 Aug; 124(2):177-86. PubMed ID: 9706136
[TBL] [Abstract][Full Text] [Related]
20. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
